Steven Campbell, MD, PhD, urologist, Cleveland Clinic, discusses the goals of the newly updated guidelines in renal cell carcinoma (RCC).

For physicians, the new guidelines provide a strong evidence-based approach, collected by experts in each area of localized RCC.

Videos

Steven Campbell, MD, PhD, urologist, Cleveland Clinic, discusses the goals of the newly updated guidelines in renal cell carcinoma.

Dr. Campbell Discusses the Goals of the New RCC Guidelines

Steven Campbell, MD, PhD, urologist, Cleveland Clinic, discusses recent advancements in the management of kidney cancer.

The new guidelines for kidney cancer are extremely rich, says Campbell, which is a departure from the basic indexing that has been the standard since 2009.

The functional aspects of the evaluation and management of patients are emphasized in these new guidelines, explains Campbell, including recommendations on staging and who should be referred to the nephrologist.

Dr. Campbell Discusses Advancements in Kidney Cancer Management

Steven Campbell, MD, PhD, urologist, Cleveland Clinic, discusses the future of the treatment management for patients with renal cell carcinoma (RCC). 

In the future, researchers hope to see an increased utilization of partial nephrectomy and a more sensible utilization of radical nephrectomy, states Campbell.  

Many are advocating for a utility-based approach to renal mass biopsy, meaning it will only be applied to patients who might have their treatment management changed, explains Campbell.  

Steven Campbell, MD, PhD, urologist, Cleveland Clinic, discusses the future of the treatment management for patients with renal cell carcinoma (RCC).

Dr. Campbell on the Future of the Management of RCC

Steven Campbell, MD, PhD, urologist, Cleveland Clinic, discusses the role of radical nephrectomy according to the guidelines for patients with renal cell carcinoma (RCC). 

There is now a well-defined and limited role of radical nephrectomy according to the kidney cancer guidelines, explains Campbell.  

According to Campbell, radical nephrectomy has been over-utilized, which has led to the decrease of kidney function for many patients. The hope is that partial nephrectomy will be considered and lead to an increase in the coming years to better preserve kidney function, states Campbell.   

Steven Campbell, MD, PhD, urologist, Cleveland Clinic, discusses the role of radical nephrectomy according to the guidelines for patients with renal cell carcinoma (RCC).

Dr. Campbell on Radical Nephrectomy in RCC

Steven Campbell, MD, PhD, urologist, Cleveland Clinic, discusses the recent guidelines for the management of patients with kidney cancer.

The main objective of these guidelines was to provide recommendations for the evaluation and management of localized kidney cancer, explains Campbell.

These guidelines are an evidence-based approach to the evaluation, counseling and selective utilization of renal mass biopsy. Additionally, each of the management options are reviewed, states Campbell.

Steven Campbell, MD, PhD, urologist, Cleveland Clinic, discusses the recent guidelines for the management of patients with kidney cancer.
 

Steven Campbell, MD, PhD

Articles

Dr. Campbell Discusses the Goals of the New RCC Guidelines

Dr. Campbell Discusses Advancements in Kidney Cancer Management

Dr. Campbell on the Future of the Management of RCC

Dr. Campbell on Radical Nephrectomy in RCC

Dr. Campbell on the Guidelines for the Management of Kidney Cancer